Pharming Group N.V.
PHAR
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 20-F/A |
4/13/2026 |
Q4 |
2025 |
12/31/2025
|
SEC |
view |
|
| 20-F |
4/2/2026 |
Q4 |
2025 |
12/31/2025
|
SEC |
view |
|
| 20-F |
4/2/2026 |
Q4 |
2025 |
12/31/2025
|
SEC |
view |
|
| WIREPR |
5/8/2025 |
Q1 |
2025 |
3/31/2025
|
WIRE |
view |
data |
| 20-F |
4/4/2025 |
Q4 |
2024 |
12/31/2024
|
SEC |
view |
|
| WIREPR |
4/3/2025 |
Q4 |
2024 |
12/31/2024
|
WIRE |
view |
data |
| WIREPR |
3/13/2025 |
Q4 |
2024 |
12/31/2024
|
WIRE |
view |
data |
| WIREPR |
5/8/2024 |
Q1 |
2024 |
3/31/2024
|
WIRE |
view |
data |
| WIREPR |
4/4/2024 |
Q4 |
2023 |
12/31/2023
|
WIRE |
view |
data |
| 20-F |
4/4/2024 |
Q4 |
2023 |
12/31/2023
|
SEC |
view |
|
| WIREPR |
3/14/2024 |
Q4 |
2023 |
12/31/2023
|
WIRE |
view |
data |
| 20-F |
4/5/2023 |
Q4 |
2022 |
12/31/2022
|
SEC |
view |
|
| WIREPR |
3/16/2023 |
Q4 |
2022 |
12/31/2022
|
WIRE |
view |
data |
| WIREPR |
10/27/2022 |
Q3 |
2022 |
9/30/2022
|
WIRE |
view |
data |
| 20-F |
4/6/2022 |
Q4 |
2021 |
12/31/2021
|
SEC |
view |
|
| 20-F |
4/7/2021 |
Q4 |
2020 |
12/31/2020
|
SEC |
view |
|